Last reviewed · How we verify

Skin Xenotransplant

XenoTherapeutics, Inc. · Phase 3 active Small molecule

A bioengineered porcine skin xenotransplant provides temporary or permanent replacement of damaged or missing human skin through cross-species tissue grafting.

A bioengineered porcine skin xenotransplant provides temporary or permanent replacement of damaged or missing human skin through cross-species tissue grafting. Used for Severe thermal burns, Chronic wounds, Acute wound coverage.

At a glance

Generic nameSkin Xenotransplant
Also known asrealSKIN®
SponsorXenoTherapeutics, Inc.
Drug classXenotransplant
ModalitySmall molecule
Therapeutic areaWound Care / Regenerative Medicine
PhasePhase 3

Mechanism of action

Skin xenotransplants utilize genetically modified porcine (pig) skin tissue to serve as a biological dressing or permanent graft for severe burn wounds, chronic wounds, or other conditions requiring skin replacement. The xenogeneic tissue is processed to minimize immunogenic rejection while providing structural support, barrier function, and biological activity to promote wound healing and tissue regeneration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results